The FDA approved Wegovy for use in a form of liver disease.
www.marketwatch.com
#Novo #Nordisk #shares #rising #FDA #approves #Wegovy
Novo Nordisk shares are rising. The FDA approves another use for Wegovy.
Related Posts
Why Qualcomm is paying $2.4 billion for Britain’s Alphawave
Qualcomm on Monday sealed a deal to acquire Britain’s Alphawave IP Group in what the company said was an effort…
CB keeps markets guessing on rates, warns of ‘layer cake of shocks’
ContentsA ‘layer cake’ of shocksECB in ‘crisis mode’ With less than 2 weeks remaining until the next European Central Bank…
Brown-Forman (BF-B) Climbs 9.6% on Pernod Ricard Merger
ContentsA ‘layer cake’ of shocksECB in ‘crisis mode’ Brown-Forman Corp. (NYSE:BF-B) is one of the 10 Stocks Investors Dominating the…